Skip to content
  • 6,807 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Combined synopsis and solicitation

Department Of Defense, Drug Demand Reduction Program (DDRP) - d-amphetamine and d-methamphetamine Immunoassay Reagent Kits

N6264520240419

Department of the Navy, NAVSUP FLT Log CTR Norfolk. In-Vitro Diagnostic Substance Manufacturing.

13 open like this View on SAM.gov Markdown

Response deadline

September 6, 2024 at 5:30 PM EDT

Closed 786 days ago. Posted August 9, 2024, first published August 7, 2024. Scheduled to archive September 21, 2024.

Get the next one like this from Department of the Navy by email, the day it is posted.Find my opportunities

This one closed in 2024

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

See combined synopsis/solicitation for more information. The materials shall be for the initial (screen) immunoassay for the detection of both d-amphetamine (DAMP) and d-methamphetamine (DMETH) in urine when present individually, or in combination, at a concentration equal to or greater than 500 ng/mL.

The reagent shall be compatible with the Beckman Coulter AU5800 Series Clinical Chemistry Analyzers in use at the Department of Defense (DOD) Forensic Toxicology Drug Testing Laboratories (FTDTLs), without modification of the equipment. The immunoassay procedure is limited to a two reagent assay procedure. A vendor’s reagent proposal which requires a separate pretreatment of each testing specimen prior to testing on the analyzer will not be considered acceptable.

The reagent shall be compatible with the optimal throughput of the analyzer systems and shall not interfere with the optimum performance of the other immunoassay procedures performed on these instruments. The reagent shall not impose additional maintenance, servicing, or calibration requirements for the optimum performance of the contractor’s reagent on the analyzer.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 7, 2024

    Combined synopsis and solicitation

    Due September 6, 2024 at 5:30 PM EDT. SAM.gov, notice f7544d70ac6f45728ab5b1a7c5e0027d

  2. August 9, 2024

    Combined synopsis and solicitation

    Due September 6, 2024 at 5:30 PM EDT. SAM.gov, notice 7468f2058ca14aa7ae52b499c806ed2b

Points of contact